A certificate of analysis can answer a laboratory question. It cannot answer every marketing question. Turning one test result into “safe,” “clinically proven” or “approved” may create a promise the document never supported.
Use a COA to explain the result it actually contains. Before placing a purity percentage or laboratory badge in an ad, match the claim to the product, batch, method and evidence. Then assess whether that product and promotion are eligible in the destination market and on the chosen platform.
In this guide
Start with the sentence you want to publish
Write the proposed claim in plain English before choosing the graphic. “A report is available for this batch” describes document availability. “This product delivers a health outcome” makes a different claim. A number in a laboratory report does not connect those statements by itself.
The US Federal Trade Commission's health-products guidance explains that both explicit and implied claims need appropriate substantiation before an ad is published. It also emphasizes the overall message a reasonable consumer takes from the advertising. A factual fragment can therefore sit inside a misleading larger impression. FTC Health Products Compliance Guidance.
Ask the reviewer to read the headline, product name, image and badge as a single message. If the headline promises a human benefit while the only evidence is an analytical report, the evidence and the claim do not match. Resolve that mismatch before making the badge more attractive.
Match the report to the actual product
Create a document check that someone outside the marketing team owns. Verify the laboratory identity, report reference, sample identity, relevant batch, date and methods. Confirm that the report is authentic and that the business is authorized to publish it. Do not simply download a supplier's image and assume it represents current stock.
Use the laboratory or a qualified technical reviewer to interpret the results. Different methods answer different questions, and a headline percentage can lose its meaning when separated from the method and limits. Marketing should not infer that a result establishes every aspect of product quality.
| Evidence item | What to verify | What it does not establish by itself |
|---|---|---|
| Batch reference | Connection to the stock being advertised | The same result for every past or future batch |
| Analytical result | Method, units and reported interpretation | A broad promise of safety or effectiveness |
| Laboratory identity | Authentic report and accurate relationship | Endorsement of the brand or advertisement |
| Ingredient study | Material and conditions actually studied | The same effect in a finished formula |
| Document date | Relevance to the current claim and stock | A guarantee that nothing has changed |
Keep purity, quantity and health outcomes separate
Do not translate an analytical purity statement into a quantity claim without evidence that supports that interpretation. Do not infer sterility, suitability for administration or human safety from a general quality statement. These questions require their own appropriate assessments; they are not decorative synonyms for tested.
For cosmetics, the EU claims regulation specifically addresses evidence for extrapolating ingredient properties to a finished product. A scientific paper about one material is not automatically a finished-formula performance claim. EU cosmetic claims criteria.
For research products, keep the technical context genuine. A report should help a legitimate buyer assess the material for a lawful research purpose. Pairing it with consumer transformation claims can communicate an entirely different intended use. No amount of analytical documentation makes an ineligible consumer offer suitable for advertising.
Design a readable evidence concept
A useful creative can explain the availability and relevance of documentation without pretending that the document grants approval. Consider a restrained product photograph, a clear statement about the specific report and a destination where the buyer can read the relevant information. Keep the visual hierarchy focused on the actual offer.
Use only genuine report excerpts when they are appropriate to publish. Never generate fictional laboratory signatures, accreditation marks, chromatograms or certificate numbers for a live product advertisement. A concept image may illustrate the idea of documentation, but it should not look like evidence for a batch that was never tested.
Make any limits visible where they matter. If a statement applies to a particular batch or test, do not place that qualification so far from the claim that the ordinary reading becomes universal. Ask a fresh reviewer what they think has been proven after seeing the ad for a few seconds.
Build a claim ledger that survives new batches
Store the exact approved wording beside its source, scope and review owner. Include the product and markets where the claim may be used. Give the creative team a usable fact set, not an invitation to turn every technical phrase into a stronger sales line.
When a new batch arrives, review which active materials refer to the old one. A campaign may continue serving long after the warehouse changes stock. Decide whether a batch-specific asset must be replaced, whether the page needs updated documentation and whether the original statement remains accurate.
Apply the same process to affiliates, creators and support templates where relevant to your business. A carefully reviewed banner can be undermined by a follow-up message that adds an unsupported safety promise. Make the boundaries easy for the whole team to understand.
Resolve the common COA questions
Can we say third-party tested?
Only use a factual testing statement that accurately describes the arrangement and scope. Verify who performed the work, what was tested and which product it covers. Avoid implying a broader independent endorsement.
Does a high purity percentage mean Meta will accept the ad?
No such conclusion follows. Product eligibility, advertiser requirements, claims and the destination still need review under the current Meta product policy.
What should go in the final creative brief?
Include the exact supported sentence, the matching evidence, its limitations, the intended buyer and the final destination. That lets a designer improve clarity without inventing proof.
Adnoxx can organize the campaign workflow around that reviewed brief. Explore account management and use evidence as a boundary for creative decisions, not as a substitute for product eligibility. Official sources reviewed on 11 October 2026.
